Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line

NCT00191854 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: gemcitabine
DRUG: paclitaxel
DRUG: carboplatin
DRUG: cisplatin

Sponsor

Eli Lilly and Company